NINDS SBIR Phase I
Funds small-business feasibility research for neuroscience technologies advancing toward later commercialization in the United States.
The National Institute of Neurological Disorders and Stroke (NINDS) Small Business Program supports innovative small business R&D at the applied bench, translational, and early-stage clinical trial levels through the congressionally mandated SBIR and STTR set-aside programs. NINDS Phase I SBIR grants (R43) fund feasibility studies for commercial innovations targeting neurological disorders, stroke…
Applied bench research, translational research, and early-stage clinical trials for neurological disorders, stroke, epilepsy, pain, and brain conditions.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline
Sign up free to see where teams trip up